Quadruple viable bacterium preparation and application thereof
The invention provides a quadruple viable bacterium preparation, which is prepared from lactobacillus acidophilus, bifidobacterium lactis, lactobacillus rhamnosus and lactobacillus paracasei, the viable count of the lactobacillus acidophilus is not less than 1*10 CFU/g, the viable count of the bifid...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides a quadruple viable bacterium preparation, which is prepared from lactobacillus acidophilus, bifidobacterium lactis, lactobacillus rhamnosus and lactobacillus paracasei, the viable count of the lactobacillus acidophilus is not less than 1*10 CFU/g, the viable count of the bifidobacterium lactis is not less than 1*10 CFU/g, the viable count of the lactobacillus rhamnosus is not less than 1*10 CFU/g, and the viable count of the lactobacillus paracasei is not less than 1*10 CFU/g. On the premise of low-dose administration, the quadruple viable bacterium preparation can significantly improve the immunity of a body.
本发明提出了一种四联活菌制剂。该四联活菌制剂包括:嗜酸乳杆菌、乳双歧杆菌、鼠李糖乳杆菌以及副干酪乳杆菌。其中,嗜酸乳杆菌的活菌量不低于1×109CFU/g,乳双歧杆菌的活菌量不低于1×109CFU/g,鼠李糖乳杆菌的活菌量不低于1×109CFU/g,副干酪乳杆菌的活菌量不低于1×109CFU/g。该四联活菌制剂在低剂量给药的前提下,可显著提高机体的免疫力。 |
---|